Lisdexamfetamine Dimesylate 42858-0165
Product NDC
42858-0165- Manufacturer
- Rhodes Pharmaceuticals Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 30, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA215330
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 50 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE, PLASTIC (42858-165-01)